ICH/EMA: Adoption of the ICH M15 guideline on general principles for model-informed drug development

Read full text Summarise with VIRAT
Authors: vroby
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This guideline defines an harmonised framework for evaluating MIDD evidence and provides recommendations for related planning and regulatory interactions, implementation, reporting, and submission. In the rapidly evolving landscape of drug development, model-informed drug development (MIDD) evidence is playing an increasingly crucial role in guiding decisions made by drug developers, regulatory authorities, and other key stakeholders. To streamline the assessment of this valuable evidence, ...

Fields of Study & Subjects

Pharmaceutical studies and practices Statistical Methods in Clinical Trials Pharmacogenetics and Drug Metabolism

Publication details

Journal / source
Hypotheses (OpenEdition)
Publication date
28 March 2026
Language
EN